MiCardia wins FDA approval for Dynaplasty annuloplasty devices
These are said to be MiCardia’s first Dynaplasty technology products to receive clearance. MiCardia is developing the Dynaplasty technology for the percutaneous and non-invasive treatment of structural heart
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.